The U.S. FDA has approved the second non-prescription opioid overdose reversal drug called "RiVive," a nasal spray version of naloxone.

The U.S. Food and Drug Administration has approved the prescription-free sale of the second opioid overdose reversal drug, its manufacturer Harm Reduction Therapeutics said on Friday.

  • @MicroWaveOP
    8•11 months ago

    The approval of the drug, called RiVive, will provide patients with another over-the-counter option in the United States, where drug-related overdose deaths surpassed 100,000 in 2021.